Table 2 Clinical data of the studied group
From: Elimination of nasal obstruction improves pulmonary functions and oxygenation
Character | Value |
|---|---|
Nasal obstruction | 59 (100%) |
Rhinorrhea | 51 (86.4%) |
Headache | 49 (83.1%) |
Postnasal discharge | 48 (81.4%) |
Sneezing | 31 (52.5%) |
Itching | 29 (49.2%) |
Snoring | 23 (39%) |
Epistaxis | 23 (39%) |
Dyspnea | 23 (39%) |
Temporal discomfort | 15 (25.4%) |
Smell disorders | 13 (22%) |
Cough | 13 (22%) |
Nocturnal apnea | 3 (5.1%) |
Operative indication | |
- Nasal polyposis | 47 (79.7%) |
- Deviated nasal septum | 12 (20.3%) |
RBCs | 5.0 ± 0.4 (4.3–6) |
Platelet count | 269.9 ± 50.5 (160–388) |
Comorbidities | |
HCV positive | 2 (3.4%) |
Duration of nasal obstruction (years) | Median 5 (2–12) |